risks of glp 1 inhibitors INFOGRAPHIC: The Hidden GLP-1 Weight Loss Medications The GLP-1 Agonists and Obesity:
Description
report here on a GIPR antagonist conjugated to GLP-1 analogues that reduces body weight and improves metabolic markers in preclinical and phase 1 clinical settings.
PMCID: PMC7153899
Two major ongoing trials are likely to change that, with potentially big implications for clinical practice.
Prebiotics are dietary fibers that nourish the beneficial bacteria in our gut
Shop MB-1: Science-Backed Metabolism Support arrae
A recent study shows that metabolic surgery delivers more effective and durable obesity outcomes than GLP-1 therapy, where real-world discontinuation exceeds 5070%
